Physician profile
Jonathan M Perry
NPI 1083844963
$573.46
in general payments reported to CMS, 2019-2025
9 companies · $161 in 2025
The $161 reported for 2025 was more than what 76% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.53 · 2024: $396 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $573.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $142.25 | 2024 | Entyvio, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $93.33 | 2023-2024 | Trulance |
| Merck Sharp & Dohme LLC | $70.63 | 2025 | Bridion |
| Janssen Biotech, INC. | $63.22 | 2024-2025 | Tremfya, Stelara |
| Terumo Medical Corporation | $53.84 | 2025 | Tr Band |
| Genzyme Corporation | $53.61 | 2024 | |
| Ironwood Pharmaceuticals, INC | $38.64 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $31.96 | 2024 | Iovera, Exparel |
| Madrigal Pharmaceuticals | $25.98 | 2024 | Resmetirom |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.